Insight

Francisco J. Esteva: The NeoSTEEP initiative

Photo of Francisco J. Esteva/LinkedIn

Aug 12, 2024, 12:38

Francisco J. Esteva: The NeoSTEEP initiative

Lenox Hill Hospital shared a post on LinkedIn:

“The NeoSTEEP initiative provides critical standardized definitions for efficacy endpoints in neoadjuvant breast cancer trials, ensuring the comparability of trial results.

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

Authors: Jennifer K Litton, Meredith M Regan, Lajos Pusztai, Hope S Rugo, Sara M Tolaney, Elizabeth Garrett-Mayer, Laleh Amiri-Kordestani, Reva K Basho, Ana F Best, Jean-Francois Boileau, Carsten Denkert, Jared C Foster, Nadia Harbeck, Heather A Jacene, Tari A King, Ginny Mason, Ciara C O’Sullivan, Tatiana M Prowell, Andrea L Richardson, Karla A Sepulveda, Mary Lou Smith, Judy A Tjoe, Gulisa Turashvili, Wendy A Woodward, Lynn Pearson Butler, Elena I Schwartz, and Larissa A Korde.

Source:

cancer Elena I Schwartz Francisco J. Esteva Jennifer K Litton Lajos Pusztai Larissa A Korde Lenox Hill Hospital Lynn Pearson Butler Meredith M Regan NeoSTEEP OncoDaily Oncology

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology